|Previous Section||Index||Home Page|
Dr. Kumar: To ask the Secretary of State for Health (1) how many people were diagnosed with (a) osteoporosis and (b) dementia in (i) England, (ii) the North East, (iii) Tees Valley and (iv) Middlesbrough South and East Cleveland constituency in each of the last 10 years; 
(2) how many people have been diagnosed with Alzheimers disease in (a) England, (b) North East, (c) Tees Valley and (d) Middlesbrough South and East Cleveland constituency in each of the last five years. 
Phil Hope: The Department does not collect information on the number of people diagnosed with osteoporosis or dementia in each of the last 10 years. However, the Dementia UK report, published in 2007 by the Alzheimers Society, estimated that there were 683,597 people in the United Kingdom with dementia.
The Department does not have data for the number of people diagnosed with Alzheimers disease in the last five years but the Department through the national Quality and Outcomes Framework for England records the number of people recorded on practice disease registers with a diagnosis of dementia covering 2006-07 and 2007-08.
|(1) This PCT was formerly known as North Tees.|
Mr. Scott: To ask the Secretary of State for Health on what dates meetings took place between Ministers of his Department and representatives of Quality Health Ltd. in the last 12 months; which Ministers attended each meeting; whether minutes were kept of each meeting; and what other communications his Department has had with Quality Health Ltd. during that period. 
Quality Health Ltd. has a relationship with the Department acting in its capacity as a sub-contractor to Northgate Information Solutions Ltd., the company awarded in February 2009 a three-year contract to support the implementation of the Departments Patient Reported Outcome Measures programme.
During mobilisation of the Patient Reported Outcome Measures programme, Departmental officials have had a significant volume of communications with Quality Health Ltd. either directly or indirectly, in writing, in person and by telephone over the period in question.
Prior to contract award, communications have taken place as part of the normal procurement process. These communications were no different to those had with all bidders. Communications have included a Quality Health Ltd. representative attending Market Information Day events to which potential bidders were invited, and Quality Health Ltd. representatives also attending formal interviews in their capacity as a member of the short-listed bidders bid team.
Direct communications have also taken place in relation to implementation of the Patient Reported Outcome Measures programme. Communications began once Northgate Information Solutions Ltd. were notified of their status as preferred bidder and had decided to work towards implementation ahead of contract signature at their own risk.
On 3 March 2009, subsequent to contract signature, a camera crew contracted to Quality Health Ltd. recorded an interview with my noble Friend the Parliamentary Under-Secretary of State (Lord Darzi) to form part of a training video about Patient Reported Outcome Measures.
Dawn Primarolo: Data on the number of diagnoses of sexually transmitted infections (STIs) in genitourinary medicine (GUM) clinics is only available by strategic health authority (SHA). The following table gives the number of diagnoses of STIs in GUM in the London SHA between 2003 and 2007, the latest year for which figures are available.
|(1) Includes diagnoses defined the in notes 5 and 6 to the following table|
1. The data available from the KC60 statutory returns are for diagnoses made in GUM clinics only. Diagnoses made in other clinical settings, such as General Practice, are not recorded in the KC60 dataset.
2. The data available from the KC60 statutory returns are the number of diagnoses made, not the number of patients diagnosed.
3. The information provided has been adjusted for missing clinic data.
4. Data are unavailable for 2008.
5. New STI diagnoses include: Chlamydial infection (uncomplicated and complicated), Gonorrhoea (uncomplicated and complicated), Infectious syphilis, Genital Herpes, simplex (first attack), Genital warts (first attack), New HIV diagnosis, Non-specific genital infection (uncomplicated and complicated), Chancroid/lymphogranuloma venerum (LGV)/Donovanosis, Molluscum contagiosum, Trichomoniasis, Scabies, Pediculus pubis.
6. Other STI diagnoses include: Early latent, congenital and other acquired syphilis, Recurrent genital Herpes simplex, Recurrent and re-registered genital warts, Subsequent HIV presentations (including AIDS), Ophthalmia neonatorum (chamydial or gonococcal), Epidemiological treatment of suspected STIs (syphilis, Chlamydia, gonorrhoea, non-specific genital infection).
Health Protection Agency, KC60 returns
In addition to STIs diagnosed in GUM clinics, the National Chlamydia Screening Programme (NCSP) provides Chlamydia screening to asymptomatic people under the age of 25 years of age in England. The NCSP was launched in 2003, when a phased implementation started. The following table shows the number of diagnoses made of Chlamydia in patients between the ages of 15-24 years between 1 April 2003 and 31 December 2008 London Primary Care Trusts (PCTs).
|(1) Cell size of 1 to 4 has been masked to protect deductive disclosure in accordance with Office of National Statistics guidelines.|
1. The NCSP has been phased in since 2003 with all 152 PCTs reporting data to the programme since March 2008. Therefore note that numbers of diagnoses have risen substantially as an increasing proportion of the target population have been tested.
2. NSCP data are presented by PCT of residence.
3. The data from the NCSP Core Dataset are for Chlamydia screens conducted within the NCSP outside of GUM clinics only.
4. The data available from the NCSP are the number of diagnoses made and not the number of patients diagnosed.
5. Data include Chlamydia tests for males, females, and those with unknown/unspecified sex.
6. Data presented are based on tests with confirmed positive diagnoses only.
National Chlamydia Screening Programme Core Dataset
|Next Section||Index||Home Page|